AstraZeneca’s $1.5B AI Drug Discovery Initiative
AstraZeneca (AZN) sealed a deal worth up to $1.5 billion with AI therapeutics firm Insitro on...
Read Moreby Editorial Staff | Oct 16, 2026 | Health | 0
AstraZeneca (AZN) sealed a deal worth up to $1.5 billion with AI therapeutics firm Insitro on...
Read Moreby Editorial Staff | Oct 15, 2026 | Health | 0
GSK plc (GSK.L / GSK) committed more than $800 million on Friday to build a next-generation...
Read Moreby Editorial Staff | Oct 8, 2026 | Health | 0
AstraZeneca (AZN) said Monday it will deploy more than $1 billion in Massachusetts as part of a...
Read Moreby Editorial Staff | Sep 28, 2026 | Health | 0
The FDA approved AbbVie’s (ABBV.N) once-daily Parkinson’s pill Juvmo on Friday,...
Read Moreby Editorial Staff | Sep 22, 2026 | Health | 0
Roche (ROG.SW) said its experimental drug enicepatide meaningfully cut blood-sugar levels and body...
Read Moreby Editorial Staff | Sep 8, 2026 | Health | 0
A neuromuscular drug candidate acquired by Novartis (NVS) through its $12 billion Avidity...
Read Moreby Editorial Staff | Sep 4, 2026 | Health | 0
Ionis Pharmaceuticals (IONS.O) secured FDA approval Thursday for zilganersen (Zanvastro), the...
Read Moreby Editorial Staff | Sep 3, 2026 | Health | 0
Nestlé (NESN.S) is directing 2 billion reais ($392.73 million) into its Brazilian nutrition and...
Read Moreby Editorial Staff | Sep 1, 2026 | Health | 0
Novartis (NVS) suspended eight clinical trials of its experimental CAR-T cell therapy for...
Read Moreby Editorial Staff | Sep 1, 2026 | Health | 0
JBS co-owner Joesley Batista met President Trump on August 20 to pitch lower Brazilian beef import...
Read Moreby Editorial Staff | Aug 25, 2026 | Health | 0
Johnson & Johnson (JNJ.N) secured an expanded FDA approval Monday for Imaavy as the first-ever...
Read Moreby Editorial Staff | Aug 24, 2026 | Health | 0
Regenxbio (RGNX) shares plunged roughly 22% on Monday after regulators placed a clinical hold on...
Read More